Ginwa Enterprise Group Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ginwa Enterprise Group Inc. with three other
companies in this sector in China:
Coland Holdings Limited
sales of 675.24 million Chinese Renmimbi [US$102.67 million]
of which 100%
was Medical Services),
Shanghai Fudan Forward S&T Co Ltd
(670.57 million Chinese Renmimbi [US$101.96 million]
of which 56%
was Industrial), and
Zhejiang Starry Pharmaceutical Co Ltd
(672.75 million Chinese Renmimbi [US$102.29 million]
of which 99%
was Pharmaceuticals Industry).
During the year ended December of 2016, sales at
Ginwa Enterprise Group Inc. were 666.08 million Chinese Renmimbi (US$101.28 million).
decrease of 8.5%
versus 2015, when the company's sales were 727.82 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 54.0% decline
in Pharmaceutical Commerce, from 308.83 million Chinese Renmimbi to 142.02 million Chinese Renmimbi.
There were also decreases in sales in
Hotel (down 3.9% to 38.74 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Pharmaceutical Industry (up 27.6% to 486.20 million Chinese Renmimbi)